Machine Learning Identification and Animal Model Validation of Key Genes for Lipid Metabolism in Diabetic Nephropathy

Area of Science:

• Genomics
• Metabolomics
• Nephrology

Background:

• Diabetic nephropathy (DN) is a major complication of diabetes, characterized by progressive kidney damage.
• Dysregulation of lipid metabolism is increasingly recognized as a key factor in DN pathogenesis.
• Identifying specific genes involved in lipid metabolism is crucial for understanding DN and developing diagnostic tools.

Purpose of the Study:

• To identify key genes regulating lipid metabolism in diabetic nephropathy (DN) using machine learning and an animal model.
• To validate the expression patterns and diagnostic potential of identified core genes in DN.

Main Methods:

• Differential gene expression analysis on transcriptome datasets (69 samples).
• Machine learning techniques (LASSO, SVM-RFE, Random Forest) and protein-protein interaction network analysis to screen core genes.
• Validation using a mouse model of type 2 diabetes mellitus.

Main Results:

• Three core genes—APOO, ALDH7A1, and ALB—were identified as significantly associated with lipid metabolism in DN.
• Expression levels of APOO, ALDH7A1, and ALB were found to be downregulated in DN.
• Experimental validation in a diabetic mouse model confirmed the altered expression of these genes in DN.

Conclusions:

• APOO, ALDH7A1, and ALB are proposed as novel diagnostic markers for lipid metabolism in DN.
• These findings offer new insights into the molecular mechanisms underlying lipid metabolism alterations in DN.
• The identified genes hold potential for improving diagnostic strategies for diabetic nephropathy.